Clinic Directory — coming soon. Are you an Australian peptide clinic?Apply to be listed →
Independent · Australian · Education only — not medical adviceAboutEditorial standardsHow we review
HomeEncyclopediaLarazotide

Larazotide

Tight-junction regulator (investigational)

Investigational

What it is

An investigational peptide studied for coeliac disease, acting on the gut lining.

What the evidence shows

Studied in trials for coeliac disease; not established or approved.

Safety & reported risks

Investigational; outside trials it is unregulated with uncertain quality.

Status in Australia

Investigational — not approved as a medicine in Australia.

How it’s lawfully accessed

No lawful consumer supply. Access would be via an approved clinical trial.

Related peptides

KPVAnti-inflammatory tripeptideResearch / unapprovedBPC-157Body Protection CompoundNot ARTG-approved

Sources & further reading

This entry is general information about Larazotide, not a recommendation to use it. We don’t provide dosing, protocols or sourcing. Speak to a registered practitioner.

Written by The Peptides.au editorial team
Editorial review Checked against current TGA, ARTG and AHPRA public guidance
Last updated 1 June 2026

This is general education, not medical advice. Peptides.au does not sell, supply, recommend or promote any product or clinic. Always speak with a registered Australian health practitioner before making any health decision.